Stefan Schneid, Bayer
Stefan Schneid
Scientific Lead Parenterals

Dr. Stefan Schneid is currently the Scientific Lead Parenterals in Drug Product Development and Science Fellow at Bayer AG. He is responsible for scientific and strategic advancement of formulation and process development for novel biological entities, small molecules and new modalities. He is involved in development projects from the preclinical stage up to transfer to commercial production. Previously, Stefan worked as a Laboratory Head in Bayer’s parenteral formulation development group. Prior to joining Bayer, he was a R&D manager at Syntacoll, where he was responsible for developing novel formulations for drug-containing biodegradable implants. Stefan was a post-doctoral research fellow in the freeze-drying focus group at the University of Erlangen and spent one year as a visiting scientist in Prof. Michael Pikal’s lab at the University of Connecticut. Stefan holds a degree in pharmacy from the University of Munich and a Ph.D. in pharmaceutics from the University of Erlangen.